Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Mama Fa'aalia Ata

Lasofoxifene Tartrate CAS 190791-29-8 Chiral Mama ≥99.0% Mama ≥98.0% (HPLC) API Mama maualuga

Fa'amatalaga Puupuu:

Igoa vaila'au: Lasofoxifene Tartrate

CAS: 190791-29-8

Fa'aaliga: Pa'epa'e i le Pa'epa'e Pa'epa'e

Amio mama: ≥99.0%Mama: ≥98.0% (HPLC)

I le togafitiga o Postmenopausal Osteoporosis

API Tulaga Maualuga, Gaosiga Fa'apisinisi

Inquiry: alvin@ruifuchem.com

Auina imeli ia matou

Fa'amatalaga Oloa

Oloa Fa'atatau

Faailoga o oloa

Fa'amatalaga:

Tuuina atu a le Faumea ma le Mamalu Maualuga ma le Tulaga Lelei
Igoa vaila'au: Lasofoxifene Tartrate
CAS: 190791-29-8
Lasofoxifene Tartrate (CAS: 190791-29-8) ile togafitiga ole Postmenopausal Osteoporosis

Meatotino tau vailaau:

Igoa Vailaau	Lasofoxifene Tartrate
Synonyms	(5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol Tartrate Oporia
Numera CAS	190791-29-8
CAT Numera	RF-API20
Tulaga Fa'asoa	I Fa'atauga, Oloa Fua e O'o i le selau Kilograms
Fuafua mole	C28H31NO2.ClH
Molecular Weight	450.019
Fa'ailoga	Ruifu Chemical

Fa'amatalaga:

Aitema	Fa'amatalaga
Fa'aaliga	Pa'epa'e i le Pa'epa'e Pa'epa'e
Susū (KF)	≤0.50%
Metala mamafa	≤20ppm
Chiral Mama	≥99.0%
Mama / Suʻesuʻega Metotia	≥98.0% (HPLC)
Ma'imau ile Fa'amago	≤0.50%
Toega i luga o le mumu	≤0.50%
Tulaga Su'ega	Pharmacopoeia Saina (CP);Pisinisi Tulaga
Fa'aoga	Gaoioiga Fa'afoma'i Mea'ai (API);Osteoporosis pe a uma le manava

Paket & Teuina:

afifi: Fagu, taga pepa alumini, pusa pepa, 25kg / Paʻu, poʻo le tusa ai ma manaʻoga o tagata faʻatau.

Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama, susu ma le afaina o meaola faalafua.

Tulaga lelei:

FAQ:

Talosaga:

Shanghai Ruifu Chemical Co., Ltd. o le taʻutaʻua taʻutaʻua ma tuʻuina atu le Lasofoxifene Tartrate (CAS: 190791-29-8) faʻatasi ai ma le maualuga.
Lasofoxifene Tartrate o se tupulaga lona tolu, non-steroidal selective estrogen receptor modulator (SERM).E fusifusia faʻatasi i le tagata ERalpha ma le IC50 tau o le 1.5 nM ma faʻalavelaveina le gau o ponaivi i isumu ovariectomized.I suʻesuʻega faʻafomaʻi o le osteoporosis postmenopausal, 0.5 mg / aso lasofoxifene na fesoʻotaʻi ma le faʻaitiitia o aʻafiaga o le gau o le vertebral ma le vertebral, ER-positive kanesa o le susu, fatu fatu fatu, ma le taʻavale ae o le faʻateleina o aʻafiaga o mea e tutupu i le thromboembolic vena.O le Lasofoxifene ua faʻaalia foi e galue o se agonist faʻafefe i le CB2 cannabinoid receptor, e faʻaalia ai lona gafatia e toe faʻaaogaina e avea o se togafitiga mo faʻamaoniga o le CB2 o se taulaʻiga.